A Danish multicenter study: cefoxitin versus ampicillin + metronidazole in perforated appendicitis.

Abstract	A prospective controlled randomized-block multicenter study was carried out in 209 patients undergoing surgery for perforated or ruptured appendicitis. The patients received either cefoxitin or ampicillin + metronidazole for 5 days. The treatment was started peroperatively. In both groups wound infections were found to be less than 10 per cent and no difference could be demonstrated. However cefoxitin was significantly superior to ampicillin + metronidazole in preventing intra-abdominal abscesses (P less than 0.05). Cefoxitin offers a single drug treatment that adequately reduces postoperative infectious complications in patients undergoing surgery for perforated or ruptured appendicitis.
Authors
Journal	The British journal of surgery (Br J Surg) Vol. 71 Issue 2 Pg. 144-6 (Feb 1984) ISSN: 0007-1323 [Print] England
PMID	6692110 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References	Metronidazole Cefoxitin Ampicillin
Topics	Abdomen Abscess (prevention & control) Adolescent Adult Aged Ampicillin (therapeutic use) Appendectomy Appendicitis (surgery) Cefoxitin (therapeutic use) Child Child, Preschool Drug Therapy, Combination Female Humans Male Metronidazole (therapeutic use) Middle Aged Prospective Studies Rupture, Spontaneous Surgical Wound Infection (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!